David Greenberg Biography and Net Worth

Director of ICU Medical


Mr. Greenberg is currently serving as Chief Executive Officer of HomeThrive, Inc. Mr. Greenberg joined HomeThrive, Inc. in 2018 and serves on the board of directors. Mr. Greenberg  previously served as Executive Vice President of Strategy for Medline Industries, Inc. from June 2008 to October 2018 and was a member of their Executive Board, advising top leadership on all aspects of the business. Mr. Greenberg was also responsible for Strategy, Business Development,  M&A and was a Group President overseeing Medline's distribution business, including several manufacturing and marketing divisions.

What is David C. Greenberg's net worth?

The estimated net worth of David C. Greenberg is at least $1.13 million as of August 27th, 2025. Mr. Greenberg owns 7,960 shares of ICU Medical stock worth more than $1,133,106 as of December 5th. This net worth approximation does not reflect any other assets that Mr. Greenberg may own. Learn More about David C. Greenberg's net worth.

How do I contact David C. Greenberg?

The corporate mailing address for Mr. Greenberg and other ICU Medical executives is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. ICU Medical can also be reached via phone at (949) 366-2183 and via email at [email protected]. Learn More on David C. Greenberg's contact information.

Has David C. Greenberg been buying or selling shares of ICU Medical?

David C. Greenberg has not been actively trading shares of ICU Medical during the past quarter. Most recently, on Wednesday, August 27th, David C. Greenberg bought 1,200 shares of ICU Medical stock. The stock was acquired at an average cost of $126.42 per share, with a total value of $151,704.00. Following the completion of the transaction, the director now directly owns 7,960 shares of the company's stock, valued at $1,006,303.20. Learn More on David C. Greenberg's trading history.

Who are ICU Medical's active insiders?

ICU Medical's insider roster includes Elisha Finney (Director), David Greenberg (Director), Vivek Jain (CEO & Chairman of the Board), George Lopez (Director), Virginia Sanzone (VP), Ben Sousa (Insider), Robert Swinney (Director), Christian Voigtlander (COO), and Daniel Woolson (Corporate Vice President and General Manager, Infusion Systems). Learn More on ICU Medical's active insiders.

Are insiders buying or selling shares of ICU Medical?

In the last year, ICU Medical insiders bought shares 2 times. They purchased a total of 23,129 shares worth more than $2,626,172.36. In the last year, insiders at the medical instruments supplier sold shares 12 times. They sold a total of 39,685 shares worth more than $5,386,445.58. The most recent insider tranaction occured on November, 11th when Director Elisha W Finney sold 1,285 shares worth more than $180,439.70. Insiders at ICU Medical own 1.5% of the company. Learn More about insider trades at ICU Medical.

Information on this page was last updated on 11/11/2025.

David C. Greenberg Insider Trading History at ICU Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/27/2025Buy1,200$126.42$151,704.007,960View SEC Filing Icon  
5/13/2025Sell1,942$143.66$278,987.726,760View SEC Filing Icon  
11/27/2024Sell972$158.11$153,682.925,037View SEC Filing Icon  
See Full Table

David C. Greenberg Buying and Selling Activity at ICU Medical

This chart shows David C Greenberg's buying and selling at ICU Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ICU Medical Company Overview

ICU Medical logo
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
Read More

Today's Range

Now: $142.35
Low: $141.39
High: $144.96

50 Day Range

MA: $128.97
Low: $114.14
High: $151.90

2 Week Range

Now: $142.35
Low: $107.00
High: $175.51

Volume

305,020 shs

Average Volume

281,869 shs

Market Capitalization

$3.51 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.82